Crescita Therapeutics Inc

CTX

Company Profile

  • Business description

    Crescita Therapeutics Inc is a commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The company has three reportable segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The firm generates its revenue from Commercial Skincare Product Sales in Canada.

  • Contact

    2805, Place Louis-R-Renaud
    LavalQCH7V 0A3
    CAN

    T: +1 450 680-4722

    https://www.crescitatherapeutics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    75

Stocks News & Analysis

stocks

Strong finish to the year for overvalued ASX share

A great fiscal 2025 but investors are ahead of themselves.
stocks

Our three most overvalued ASX shares

These three companies are trading at a significant premium to our fair value.
stocks

What does big US court decision mean for Google’s parent company Alphabet?

Alphabet shares popped 7% after the ruling on September 2 and have now rallied by around 50% since April.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,080.7039.80-0.44%
CAC 407,745.8811.040.14%
DAX 4023,706.08101.05-0.42%
Dow JONES (US)45,514.95114.090.25%
FTSE 1009,239.4317.990.20%
HKSE25,938.13304.221.19%
NASDAQ21,798.7098.310.45%
Nikkei 22543,459.29184.52-0.42%
NZX 50 Index13,253.7327.41-0.21%
S&P 5006,495.1513.650.21%
S&P/ASX 2008,803.5037.40-0.42%
SSE Composite Index3,807.2919.55-0.51%

Market Movers